Lower Lead Limits For Calcium-Containing Products Shelved By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is not adopting new, lower lead limits for calcium-containing supplements and antacids at this time but "is actively investigating the feasibility of establishing lower limits," the agency tells the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a Sept. 28 letter.